The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis
Open accessAbstract
Importance: It is unclear whether female carriers of the apolipoprotein E (APOE) ε4 allele are at greater risk of developing Alzheimer disease (AD) than men, and the sex-dependent association of mild cognitive impairment (MCI) and APOE has not been established. Objective: To determine how sex and APOE genotype affect the risks for developing MCI and AD. Data Sources: Twenty-seven independent research studies in the Global Alzheimer's Association Interactive Network with data on nearly 58 000 participants. Study Selection: Non-Hispanic white individuals with clinical diagnostic and APOE genotype data. Data Extraction and Synthesis: Homogeneous data sets were pooled in case-control analyses, and logistic regression models were used to compute risks. Main Outcomes and Measures: Age-adjusted odds ratios (ORs) and 95% confidence intervals for developing MCI and AD were calculated for men and women across APOE genotypes. Results: Participants were men and women between ages 55 and 85 years. Across data sets most participants were white, and for many participants, racial/ethnic information was either not collected or not known. Men (OR, 3.09; 95% CI, 2.79-3.42) and women (OR, 3.31; CI, 3.03-3.61) with the APOE ε3/ε4 genotype from ages 55 to 85 years did not show a difference in AD risk; however, women had an increased risk compared with men between the ages of 65 and 75 years (women, OR, 4.37; 95% CI, 3.82-5.00; men, OR, 3.14; 95% CI, 2.68-3.67; P = .002). Men with APOE ε3/ε4 had an increased risk of AD compared with men with APOE ε3/ε3. The APOE ε2/ε3 genotype conferred a protective effect on women (OR, 0.51; 95% CI, 0.43-0.61) decreasing their risk of AD more (P value = .01) than men (OR, 0.71; 95% CI, 0.60-0.85). There was no difference between men with APOE ε3/ε4 (OR, 1.55; 95% CI, 1.36-1.76) and women (OR, 1.60; 95% CI, 1.43-1.81) in their risk of developing MCI between the ages of 55 and 85 years, but women had an increased risk between 55 and 70 years (women, OR, 1.43; 95% CI, 1.19-1.73; men, OR, 1.07; 95% CI, 0.87-1.30; P = .05). There were no significant differences between men and women in their risks for converting from MCI to AD between the ages of 55 and 85 years. Individuals with APOE ε4/ε4 showed increased risks vs individuals with ε3/ε4, but no significant differences between men and women with ε4/ε4 were seen. Conclusions and Relevance: Contrary to long-standing views, men and women with the APOE ε3/ε4 genotype have nearly the same odds of developing AD from age 55 to 85 years, but women have an increased risk at younger ages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“APOE-e4 was related to higher Alzheimer's risk in women than men between ages 55 to 70”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [288]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Carrying one APOE4 allele increases the risk of AD by 3–4 times, and carrying two alleles increases the risk by 9–15 times.168”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [168]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Women are more vulnerable to effects of APOE4 on memory decline [45] as well as risk for AD dementia [16] and neuropathology [46], and more limited data suggest that APOE2 also confers greater protection against AD risk for women than men [16].”
From Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status (2024) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“That is, APOE‐e4 was related to higher Alzheimer's risk in women than men between ages 55 and 70, when APOE is thought to exert its largest effects.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [314]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A recent meta-analysis found no difference between men and women in the association between APOE-e4 and Alzheimer's dementia overall, although age played an interesting interactive role.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [288]
The cited source says what the claim attributes to it.
In the citing paper
“APOE is differentially associated with AD risk across populations [16]”
From Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status (2024) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“Women are more vulnerable to effects of APOE4 on memory decline [45] as well as risk for AD dementia [16] and neuropathology [46], and more limited data suggest that APOE2 also confers greater protection against AD risk for women than men [16].”
From Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status (2024) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“However, a meta‐analysis found no difference between men and women in the association between APOE‐e4 and Alzheimer's dementia overall, although age played an interesting interactive role.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [314]
The cited source says what the claim attributes to it.
In the citing paper
“Epidemiologic studies show sex differences in clinical risk are largely discernable within the context of APOE ε4,11,42,43 particularly between the ages of 65 to 75 years compared with APOE ε4 clinically normal male carriers.44”
From Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults (2019) · cites this paper as [44]
In the citing paper
“Attempts to quantify the duration of AD should be age-specific, because age imposes the greatest risk for both dementia and mortality, and take into account APOE genotype, sex, and cerebrospinal fluid (CSF) tau levels [4, 6, 10-12].”
From Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype (2019) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. S. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,846
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857
Mild cognitive impairment: a concept in evolution
Petersen, R. C., Caracciolo, B., Brayne, C., Gauthier, S., Jelic, V., & Fratiglioni, L. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12190 · Cited by 1,694
The normal menopause transition
McKinlay, S. M., Brambilla, D. J., & Posner, J. G. (1992) · Maturitas · doi:10.1016/0378-5122(92)90003-m · Cited by 1,112
Sex Differences in Stroke Epidemiology
Appelros, P., Stegmayr, B., & Terént, A. (2009) · Stroke · doi:10.1161/strokeaha.108.540781 · Cited by 1,076
Natural history of mild cognitive impairment in older persons
Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Beckett, L. A., Aggarwal, N. T., Barnes, L. L., Fox, J. H., & Bach, J. (2002) · Neurology · doi:10.1212/wnl.59.2.198 · Cited by 1,037
Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences
Mielke, M., Vemuri, P., & Rocca, W. (2014) · Clinical Epidemiology · doi:10.2147/clep.s37929 · Cited by 1,021
Ellis, K. A., Bush, A. I., Darby, D., Fazio, D. D., Foster, J. K., Hudson, P. J., Lautenschlager, N. T., Lenzo, N. P., Martins, R. N., Maruff, P. T., et al. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209009405 · Cited by 1,005
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 691
Sex and APOE ɛ4 modify the effect of cardiovascular risk on tau in cognitively normal older adults
Tsiknia, A. A., Reas, E. T., Bangen, K. J., Sundermann, E. E., McEvoy, L. K., Brewer, J. B., Edland, S. D., Banks, S. J., & Initiative, A. D. N. (2022) · Brain Communications · doi:10.1093/braincomms/fcac035 · Cited by 17
Beam, C. R., Kaneshiro, C., Jang, J. Y., Reynolds, C. A., Pedersen, N. L., & Gatz, M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191192 · Cited by 17
Examining the contribution of histone modification to sex differences in learning and memoryPreprint
Keiser, A. A., & Wood, M. A. (2019) · Learning & Memory · doi:10.1101/lm.048850.118 · Cited by 17
Shafer, A. T., Beason-Held, L., An, Y., Williams, O. A., Huo, Y., Landman, B. A., Caffo, B. S., & Resnick, S. M. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.03.013 · Cited by 16
Frank, M., Hensel, J., Baak, L., Schramm, S. H., Dragano, N., Weimar, C., Hoffmann, P., Nöthen, M. M., Erbel, R., Jöckel, K., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210244 · Cited by 16
Jett, S., Dyke, J., Yepez, C. B., Zarate, C., Carlton, C., Schelbaum, E., Jang, G., Pahlajani, S., Williams, S., Brinton, R. D., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281302 · Cited by 15
Guerrero-González, C., Cueto‐Ureña, C., Cantón-Habas, V., Ramı́rez-Expósito, M. J., & Martı́nez-Martos, J. M. (2024) · Physiologia · doi:10.3390/physiologia4010007 · Cited by 16
Kulkarni, P. G., Mohire, V. M., Waghmare, P. P., & Banerjee, T. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101874 · Cited by 16
Liu, Y., Song, J., Xu, W., Hou, X., Li, J., Yu, J., Tan, L., Chi, S., & Initiative, A. A. D. N. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.633576 · Cited by 16
Endocrine dysfunction and cognitive impairment
Calsolaro, V., Bottari, M., Coppini, G., Lemmi, B., & Monzani, F. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.20.03295-2 · Cited by 16
Mun, Y. S., Park, H. K., Kim, J., Yeom, J., Kim, G. H., Chun, M. Y., Lee, H. A., Yoon, S. J., Park, H. K., Kim, E., et al. (2022) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2022.21.1.30 · Cited by 16
Scarfò, G., Piccarducci, R., Daniele, S., Franzoni, F., & Martini, C. (2022) · Antioxidants · doi:10.3390/antiox11112116 · Cited by 16
Choi, Y. Y., Lee, J. J., Choi, K. Y., Seo, E. H., Choo, I. H., Kim, H., Song, M., Choi, S., Cho, S. H., Kim, B. C., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.604238 · Cited by 16
Timofeeva, A. M., Aulova, K. S., & Nevinsky, G. A. (2025) · Brain Sciences · doi:10.3390/brainsci15050486 · Cited by 17
Xiong, L. Y., Alexander, M. W., Wong, Y. Y., Wu, C., Ruthirakuhan, M. T., Edwards, J. D., Lanctôt, K. L., Black, S. E., Rabin, J. S., Cogo‐Moreira, H., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02685-4 · Cited by 16
Neuroimaging and Neurolaw: Drawing the Future of Aging
Tigano, V., Cascini, G. L., Sánchez‐Castañeda, C., Péran, P., & Sabatini, U. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00217 · Cited by 15
Sex Hormones and Cognitive Functions: Current Data
Bulgakova, S. V., & Romanchuk, N. (2020) · Bulletin of Science and Practice · doi:10.33619/2414-2948/52/09 · Cited by 15
Sex-Specific Protective Effects ofAPOEε2 on Cognitive Performance
Lamonja-Vicente, N., Dacosta‐Aguayo, R., López-Olóriz, J., Prades-Senovilla, L., Roig-Coll, F., Castells-Sánchez, A., Soriano-Raya, J. J., Clemente, I. C., Miralbell, J., Barrios, M., et al. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa247 · Cited by 15
APOE ɛ4 Is Associated with Postprandial Inflammation in Older Adults with Metabolic Syndrome Traits
Schönknecht, Y. B., Crommen, S., Stoffel‐Wagner, B., Coenen, M., Fimmers, R., Stehle, P., Ramı́rez, A., & Egert, S. (2021) · Nutrients · doi:10.3390/nu13113924 · Cited by 15
Upadhya, S., Liu, H., Luo, S., Lutz, M. W., & Chiba‐Falek, O. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.827447 · Cited by 15
Sex and gender differences in dementia
Salwierz, P., Davenport, C., Sumra, V., Iulita, M. F., Ferretti, M. T., & Tartaglia, M. C. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.07.002 · Cited by 16
Wang, J., Wang, M., Ren, S., Huang, L., He, K., Li, J., Hua, F., Guan, Y., Guo, Q., Huang, Q., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221166 · Cited by 15
Self-citationAPOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid1
Berger, M., Cooter, M., Roesler, A. S., Chung, S., Park, J., Modliszeski, J. L., VanDusen, K. W., Thompson, J. W., Moseley, M. A., Devinney, M. J., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200747 · Cited by 15
McLean, J. W., Bhattrai, A., Vitali, F., Raikes, A. C., Wiegand, J. L., & Brinton, R. D. (2022) · Learning & Memory · doi:10.1101/lm.053588.122 · Cited by 15
Wang, T., Liu, X., Wang, X., Hua, F., & Yan, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1739875 · Cited by 14
Association between Apolipoprotein E genotype and functional outcome in acute ischemic stroke
Rong, X., Chen, J., Pan, D., Wang, Y., Zhang, C., & Tang, Y. (2023) · Aging · doi:10.18632/aging.204460 · Cited by 15
A case for seeking sex-specific treatments in Alzheimer’s disease
Lynch, M. A. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1346621 · Cited by 16
Serum proteomics reveals early biomarkers of Alzheimer's disease: The dual role of APOE-ε4
Ma, Y., Xia, Y., Karako, K., Song, P., Tang, W., & Hu, X. (2025) · BioScience Trends · doi:10.5582/bst.2024.01365 · Cited by 14
Phenome-wide association of APOE alleles in the All of Us Research Program
Khajouei, E., Ghisays, V., Piras, I. S., Martinez, K. L., Vicenti, A. T., Naymik, M., Ngo, P., Tran, T. C., Denny, J. C., Wheeler, T. J., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105768 · Cited by 14
Atrophy of hippocampal subfield CA2/3 in healthy elderly men is related to educational attainment
Jiang, L., Cao, X., Jiang, J., Li, T., Wang, J., Yang, Z., & Li, C. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.03.019 · Cited by 14
Self-citationYang, F. N., Bronshteyn, M., Flowers, S. A., Dawson, M., Kumar, P. N., Rebeck, G. W., Turner, R. S., Moore, D. J., Ellis, R. J., & Jiang, X. (2021) · AIDS · doi:10.1097/qad.0000000000002840 · Cited by 14
Probiotic supplement as a promising strategy in early tau pathology prevention: Focusing on GSK-3β?
Flynn, C. M., & Yuan, Q. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1159314 · Cited by 15
Polcz, V. E., Barrios, E. L., Chapin, B. A., Price, C. C., Nagpal, R., Chakrabarty, P., Casadesús, G., Foster, T. C., Moldawer, L. L., & Efron, P. A. (2023) · Clinical Science · doi:10.1042/cs20220555 · Cited by 15
Sex Differences in P-Tau217, Tau Aggregation, and Cognitive Decline
Coughlan, G., Ourry, V., Townsend, D. L., Klinger, H. M., Brown, J. A., Cuppels, M., Betthauser, T. J., Langhough, R. E., Cody, K. A., Seto, M., et al. (2026) · JAMA Neurology · doi:10.1001/jamaneurol.2025.5670 · Cited by 13
Self-citationLipoprotein Metabolism, Protein Aggregation, and Alzheimer’s Disease: A Literature Review
Grao‐Cruces, E., Claro, C., la Paz, S. M., & Nóbrega, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032944 · Cited by 15
Wang, Y.-Z., Zhao, W., Moorjani, P., Gross, A. L., Zhou, X., Dey, A. B., Lee, J., Smith, J. A., & Kardia, S. L. R. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14052 · Cited by 14
González, R., Gomes, I., Gomes, C., Rocha, R., Durães, L., Sousa, P., Figueruelo, M., Rodríguez, M. D. C., Pita, C., Hornero, R., et al. (2020) · Genes · doi:10.3390/genes12010004 · Cited by 14
The use of everyday and assistive technology in the lives of older autistic adults
Zheng, L., Foley, K., Grove, R., Elley, K., Brown, S. A., Leong, D.-J., Li, X., Pellicano, E., Trollor, J. N., & Hwang, Y. I. (2021) · Autism · doi:10.1177/13623613211058519 · Cited by 13
Pitchika, A., Markus, M. R. P., Schipf, S., Teumer, A., der Auwera, S. V., Nauck, M. A., Dörr, M., Felix, S. B., Grabe, H. J., Völzke, H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09129-5 · Cited by 13
Koire, A. M., Joffe, H., & Buckley, R. F. (2022) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000339 · Cited by 13
Gender medicine: Towards a gender-specific treatment of neuropsychiatric disorders
Biskup, E. M., Martínková, J., & Ferretti, M. T. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64123-6.00029-1 · Cited by 13
Hong, S., Han, K., Park, S. H., Kim, S. M., Kim, N. H., Choi, K. M., Baik, S. H., Park, Y. G., & Yoo, H. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa019 · Cited by 12
Barrera, J., Song, L., Safi, A., Yun, Y., Garrett, M. E., Gamache, J., Premasinghe, I., Sprague, D., Chipman, D., Li, J., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00481-0 · Cited by 14
Differences in Recycling of Apolipoprotein E3 and E4—LDL Receptor Complexes—A Mechanistic Hypothesis
Kim, M., & Bezprozvanny, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095030 · Cited by 11
Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer’s Disease in Nordic Populations
Motazedi, E., Cheng, W., Thomassen, J. Q., Frei, O., Rongve, A., Athanasiu, L., Bahrami, S., Shadrin, A. A., Ulstein, I. D., Stordal, E., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220174 · Cited by 12
Cognitive trajectories diverge by genetic risk in a preclinical longitudinal cohort
Vasiljevic, E., Koscik, R. L., Jonaitis, E. M., Betthauser, T. J., Johnson, S. C., & Engelman, C. D. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12920 · Cited by 12
Self-citationChen, X., Fortes, J. M., Hu, Y., van Iersel, J., He, K., van Heerikhuize, J. J., Balesar, R. A., Swaab, D. F., & Bao, A. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13037 · Cited by 12
Chronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal Dementia
Lesman‐Segev, O. H., Edwards, L., & Rabinovici, G. D. (2020) · Seminars in Neurology · doi:10.1055/s-0040-1715134 · Cited by 13
Pontifex, M. G., Martinsen, A., Saleh, R. N. M., Harden, G., Fox, C., Müller, M. M., Vauzour, D., & Minihane, A. M. (2022) · Nutrients · doi:10.3390/nu14091698 · Cited by 13
Italian, European, and international neuroinformatics efforts: An overview
Redolfi, A., Archetti, D., Francesco, S. D., Crema, C., Tagliavini, F., Lodi, R., Ghidoni, R., Wheeler‐Kingshott, C. A. M. G., Alexander, D. C., & D'Angelo, E. U. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15854 · Cited by 12
Self-citationAccelerated midlife endocrine and bioenergetic brain aging in APOE4 females
Wang, T., Mao, Z., Shang, Y., Merlini, S., Vitali, F., Wiegand, J. L., & Brinton, R. D. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1632877 · Cited by 12
de Muniain, L. S., Escalada, P., Ramírez, M. J., & Solas, M. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70252 · Cited by 11
Biological and Clinical Implications of Sex-Specific Differences in Alzheimer’s Disease
Santiago, J. A., & Potashkin, J. A. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_672 · Cited by 11
McFall, G. P., Bäckman, L., & Dixon, R. A. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190315094452 · Cited by 11
Dementia risk in women higher in same‐sex than opposite‐sex twins
Luo, J., Beam, C. R., Karlsson, I., Pike, C. J., Reynolds, C. A., & Gatz, M. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12049 · Cited by 15
Second to fourth digit ratio (2D:4D) is associated with dementia in women
Jiang, J., Young, K., & Pike, C. J. (2020) · Early Human Development · doi:10.1016/j.earlhumdev.2020.105152 · Cited by 11
Lee, C., Lui, D. T. W., Cheung, C. Y. Y., Woo, Y. C., Fong, C. H.-Y., Yuen, M. M. A., Shea, Y. F., Siu, D. C. W., Chan, K., Chow, W., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3401 · Cited by 11
Kulminski, A. M., Philipp, I., Loika, Y., He, L., & Culminskaya, I. V. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12413 · Cited by 11
Thompson, L. I., Cummings, M., Emrani, S., Libon, D. J., Ang, T. F. A., Karjadi, C., Au, R., & Liu, C. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.48 · Cited by 10
Self-citationCETP inhibitor evacetrapib enters mouse brain tissue
Phénix, J., Côté, J., Dieme, D., Recinto, S. J., Oestereich, F., Efrem, S., Haddad, S., Bouchard, M., & Munter, L. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1171937 · Cited by 10
Qi, Q., Deng, F., Sammon, R., Ritchie, K. A., Terrera, G. M., Koychev, I. G., Malhotra, P., Hutchinson, S., Robinson, D., O'Brien, J. T., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01610-9 · Cited by 12
Small, S. L. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102632 · Cited by 10
Egroo, M. V., Beckers, E., Ashton, N. J., Blennow, K., Zetterberg, H., & Jacobs, H. I. L. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01653-y · Cited by 10
Xie, G., Jiang, G., Huang, L., Sun, S., Wan, Y., Li, F., Wu, B., Zhang, Y., Li, X., Xiong, B., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18060790 · Cited by 10
Research Progress of Lipid Metabolism-Mediated Neuroinflammation in Alzheimer’s Disease
Shen, Y., Wang, X., Liu, X., Wang, G., Hou, X., & Zhou, X. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01648-9 · Cited by 12
Behroozi, Z., Askarpour, H., & Baghcheghi, Y. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261415807 · Cited by 10
Sex and gender differences in genetic and lifestyle risk and protective factors for dementia
Sindi, S., Toopchiani, S. T., Barbera, M., Håkansson, K., Lehtisalo, J., Rosenberg, A., Stephen, R., Udeh‐Momoh, C. T., & Kivipelto, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819344-0.00013-2 · Cited by 11
Fu, J., Huang, Y., Bao, T., Ou, R., Wei, Q., Chen, Y., Yang, J., Chen, X., & Shang, H. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.844066 · Cited by 10
Self-citationGuo, J., Orgeta, V., Olivé, I., Hoff, E. I., Huntley, J. D., Olff, M., & Sobczak, S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102198 · Cited by 10
Lei, C., Wu, G., Cui, Y., Xia, H., Chen, J., Zhan, X., Lv, Y., Li, M., Zhang, R., & Zhu, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1290286 · Cited by 10
Takeuchi, H., Tomita, H., Browne, R., Taki, Y., Kikuchi, Y., Ono, C., Yu, Z., Nouchi, R., Yokoyama, R., Kotozaki, Y., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa251 · Cited by 10
Koscik, R. L., Norton, D., Allison, S. L., Jonaitis, E. M., Clark, L. R., Mueller, K. D., Hermann, B. P., Engelman, C. D., Gleason, C. E., Sager, M. A., et al. (2018) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617718000954 · Cited by 10
Self-citationMahanta, A. K., Chaulagain, B., Gothwal, A., & Singh, J. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00465 · Cited by 10
A ketogenic diet improves memory in females in the APOE4 mouse model of Alzheimer’s disease
Lucente, J. D., Rutkowsky, J. M., Provenzano, A. E., Persico, G., Zhou, Z., Jin, L., Ramsey, J. J., Montgomery, C. B., Kim, K., Giorgio, M., et al. (2025) · GeroScience · doi:10.1007/s11357-025-01998-8 · Cited by 9
Kiris, E. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_683 · Cited by 9
Boutros, S. W., Zimmerman, B., Nagy, S. C., Unni, V. K., & Raber, J. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01966-8 · Cited by 9
Pan, F., Wang, Y., Wang, Y., Wang, X., Guan, Y., Xie, F., & Guo, Q. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.06.013 · Cited by 9
Hosseinzadeh, S., Afshari, S., Molaei, S., Rezaei, N., & Dadkhah, M. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578206 · Cited by 10
Soldevila‐Domenech, N., Fagundo, A. B., Cuenca‐Royo, A., Forcano, L., Gomis‐González, M., Boronat, A., Pastor, A., Castañer, O., Zomeño, M. D., Goday, A., et al. (2024) · Nutrition Journal · doi:10.1186/s12937-024-00966-w · Cited by 12
Dyk, K. V., Crespi, C. M., Bower, J. E., Carroll, J., Petersen, L., & Ganz, P. A. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00327-4 · Cited by 9
Chang, Y., Karageorghis, C. I., Wang, C.-C., Li, R., Chen, F., Fang, R.-Y., & Hung, T. (2022) · Current Psychology · doi:10.1007/s12144-022-03257-x · Cited by 9
Soldevila‐Domenech, N., Pastor, A., Sala‐Vila, A., Lázaro, I., Boronat, A., Muñoz, D., Castañer, O., Fagundo, A. B., Corella, D., Fernández‐Aranda, F., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1076677 · Cited by 9
Rodríguez‐Rojo, I. C., Cuesta, P., López, M. E., de Frutos‐Lucas, J., Bruña, R., Pereda, E., Barabash, A., Carrasco, P. M., Montenegro-Peña, M., Marcos, A., et al. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00684 · Cited by 11
Evans, S., McRae‐McKee, K., Hadjichrysanthou, C., Wong, M. M., Ames, D. J., López, O. L., de Wolf, F., Anderson, R. M., Initiative, A. D. N., ageing, A. I. B. A. L. F. S. O., et al. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.04.005 · Cited by 11
Ourry, V., Fajardo-Valdez, A., Soucy, J., Poirier, J., Breitner, J. C. S., & Villeneuve, S. (2025) · Neurology · doi:10.1212/wnl.0000000000213507 · Cited by 8
Lizcano, F., Sanabria, D., & Aviles, E. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1622186 · Cited by 8
Sex differences in in vivo biomarkers of neurodegenerative dementia
Mak, E., Kantarci, K., & Arvanitakis, Z. (2025) · Frontiers in Dementia · doi:10.3389/frdem.2025.1706177 · Cited by 9
Apolipoprotein E4 in Alzheimer’s Disease: Role in Pathology, Lipid Metabolism, and Drug Treatment
Al-Ghraiybah, N. F., Alkhalifa, A. E., Itokazu, Y., Farr, T., Pérez, N., Ali, H., & Kaddoumi, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27021004 · Cited by 9
Pérez-Lasierra, J. L., Casajús, J. A., Casasnovas, J. A., Arbonés-Mainar, J. M., Lobo, A., Lobo, E., Moreno‐Franco, B., & González‐Agüero, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18147238 · Cited by 9
Ng, C. A. S., Biran, L. P., Galvano, E., Mandelblatt, J. S., Vicini, S., & Rebeck, G. W. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105915 · Cited by 9
A predictive model of cognitive impairment risk in older adults with hypertension
Zuo, W., & Yang, X. (2025) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2025.111032 · Cited by 8
Wellman, S. M., Coyne, O., Douglas, M. M., & Kozai, T. D. Y. (2023) · Journal of Neural Engineering · doi:10.1088/1741-2552/aceca5 · Cited by 8
Blood Pressure and Statin Effects on Cognition: a Review
Yang, M., & Williamson, J. D. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0973-4 · Cited by 8
Endocrine dysfunction and cognitive impairment
Calsolaro, V., Bottari, M., Coppini, G., Lemmi, B., & Monzani, F. (2021) · Minerva Endocrinology · doi:10.23736/s0391-1977.20.03295-2 · Cited by 8
Lee, B. H., Puri, T. A., & Galea, L. A. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819344-0.00010-7 · Cited by 8
GenoRisk: A polygenic risk score for Alzheimer's disease
Dickson, S. P., Hendrix, S. B., Brown, B. L., Ridge, P. G., Nicodemus‐Johnson, J., Hardy, M. L., McKeany, A. M., Booth, S. B., Fortna, R. R., Kauwe, J. S. K., et al. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12211 · Cited by 8
Lifetime estrogen exposure and domain-specific cognitive performance: results from the IGNITE study
Watts, A. S., Donofry, S. D., Ripperger, H. S., Eklund, N. M., Wan, L., Kang, C., Grove, G., Oberlin, L. E., Gujral, S., Vidoni, E. D., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1524474 · Cited by 8
Alzheimer’s Disease and Other Dementias
Brugulat‐Serrat, A., Shaaban, C. E., Emrani, S., & Sundermann, E. E. (2025) · Springer eBooks · doi:10.1007/978-3-031-87228-0_5 · Cited by 7
APOE4 triggers dysregulated synaptic vesicle release by disrupting SNARE complex assembly
Chen, F., Chen, Y., Feng, S., Chen, H., Deng, L., Ma, F., Ke, Q., Liang, Q., Ji, C. F., Peng, X., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05787-6 · Cited by 7
Self-citationUnequal disease burdens: exploring the intersection of gender, health and disease dynamics in China
Yang, X., Li, R., Liu, J., Shu, J., Chen, H., Dong, M., Lv, J., Yuan, Y., Song, Q., Guo, L., et al. (2025) · BMC Public Health · doi:10.1186/s12889-025-23354-3 · Cited by 7
Metadata
- Authors
- Neu, S. C., Pa, J., Kukull, W., Beekly, D., Kuzma, A., Gangadharan, P., Wang, L.-S., Romero, K., Arneric, S. P., Redolfi, A., Orlandi, D., Frisoni, G. B., Au, R., Devine, S., Auerbach, S., Espinosa, A., Boada, M., Ruiz, A., Johnson, S. C., Koscik, R., Wang, J.-J., Hsu, W.-C., Chen, Y.-L., & Toga, A. W.
- Affiliations
- University of Southern California (US)
- University of Washington (US)
- University of Pennsylvania (US)
- Critical Path Institute (US)
- Coalition Against Major Disease, Critical Path Institute, Tucson, Arizona
- Centro San Giovanni di Dio Fatebenefratelli (IT)
- University of Geneva (CH)
- Boston University (US)
- Fundació ACE (ES)
- Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain
- University of Wisconsin–Madison (US)
- Chang Gung University (TW)
- Chang Gung Memorial Hospital (TW)
- Corresponding author
- Toga, Arthur W.
- ORCID
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2017-10-01
- Volume
- 74
- Issue
- 10
- Pages
- 1178
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC5759346
- OpenAlex
- W2745657465
- Cited by
- 674
- References
- 74
- Citations by year
- 2026: 74 · 2025: 81 · 2024: 74 · 2023: 93 · 2022: 78 · 2021: 96 · 2020: 69 · 2019: 67 · 2018: 37 · 2017: 3
- FWCI
- 39.51
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- JAMA Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000130, 5u01ag024904-10, n01hc25195-41-0-1, UL1TR001855)
- U.S. Food and Drug Administration (U18FD005320)
- National Institute on Aging (U01-AG-024904, P30AG010129, P30AG010133, P30AG028383, P30AG012300, P50AG005133, U01AG016976, P50AG005131, P50AG005138, P50AG016570, P30AG010124, P50AG016573, RF1AG027161, P50AG047366, P30AG008017, P30AG010161, R01AG033040, P30AG008051, P50AG008702, R01AG016495, P50AG033514, P30AG035982, P50AG005681, P50AG005142, P50AG047270, P30AG019610, P50AG005146, P01AG003991, RF1AG054617, P30AG013846, P50AG005136, P50AG005134, P30AG013854, P50AG025688, P50AG047266, R01AG008122, R01AG027161, U24AG041689, U19AG024904, P01AG026276, P50AG023501, P50AG016574)
- National Heart, Lung, and Blood Institute (N01-HC-025195)
- National Institute of Neurological Disorders and Stroke (R01NS017950)
- National Institute of Biomedical Imaging and Bioengineering (U54EB020406, P41EB015922)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- Alzheimer's disease, apolipoprotein E, APOE ε4, APOE ε2, sex differences, mild cognitive impairment, genetic risk factors
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Female, Humans, Male, Middle Aged, Risk Factors, Sex Characteristics, Logistic Models, Case-Control Studies, Databases, Factual
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
